Changes in the OCT angiographic appearance of type 1 and type 2 CNV in exudative AMD during anti-VEGF treatment.
Henrik FaatzMarie-Louise FareckiKai RothausMatthias GutfleischDaniel PauleikhoffAlbrecht LommatzschPublished in: BMJ open ophthalmology (2019)
OCT-A enables detailed analysis of AMD with regard to FD, aCNV, tlCNV and nsCNV. As the changes in these parameters correlate closely with changes on SD-OCT, they can be used as new activity parameters, alongside fluid distribution, for assessment of treatment effect and as parameters of stabilisation or the need for repeated treatment.